Pulmonary Arterial Hypertension Rx Combo Approved

Pulmonary Arterial Hypertension Rx Combo Approved


Together, two medications for pulmonary arterial
hypertension (PAH) may help patients even more than one pill alone. I’m Gabe Garza with
your latest health news. The FDA recently approved Letairis in combination with Adcirca
to treat PAH. The combination of these drugs appeared to slow the progression of PAH and
reduce the risk of hospitalization. PAH is high blood pressure in the arteries to the
lungs. With PAH, the blood vessels that carry blood from the heart to the lungs, become
narrow and hard. Over time, this can eventually overwork the heart, possibly leading to heart
failure. Patients taking both drugs were less likely to see a progression in their PAH when
compared to those who only took one of the two drugs. Speak to your doctor about the
latest treatment options for your condition.